Effect of ultrafiltration on priming solution with preserved blood for extracorporeal circulation in infants

ASAIO Journal

Volumn 42, Issue 5, 1996, Pages

  Shimpo, Hideto ^a   Shimamoto, Akira ^a   Miyake, Yoichiro ^a   Onoda, Koji ^a   Tani, Kazuhiro ^a   Shimono, Takatsugu ^a   Yuasa, Hiroshi ^a   Yada, Isao ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; BLOOD; CARDIOVASCULAR SURGERY; DISEASES; FILTERS (FOR FLUIDS); GLUCOSE; HORMONES; MALTOSE; PEDIATRICS; POLYSULFONES; POTASSIUM; ULTRAFILTRATION;

BRADYKININ; CREATININ; EXTRACORPOREAL CIRCULATION; PHOSPHOKINASE; PRIMING BLOOD;

HEMODYNAMICS;

BRADYKININ; KININOGEN; POLYSULFONE;

AORTA STENOSIS; ARTICLE; CAPILLARY PERMEABILITY; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; EXTRACORPOREAL CIRCULATION; FALLOT TETRALOGY; HEART VENTRICLE SEPTUM DEFECT; HUMAN; INFANT; LUNG VEIN DRAINAGE ANOMALY; OPEN HEART SURGERY; PEDIATRIC SURGERY; ULTRAFILTRATION;

EID: 0030250882     PISSN: 10582916     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002480-199609000-00098     Document Type: Article

References (8)

1. Pacifico AD, Digerness S, Kirklin JW: Acute alterations in body composition after open intracardiac opearations. Circulation 41: 331-341, 1970.
2. Naik S, Elliott M: Ultrafitration, in Jonas R, Elliott M (eds), Cardiopulmonary Bypass in Neonates, Infants and Young Children. Oxford, Butterworth-Heineman Ltd, 1994, pp. 158-172.
3. Nagaoka H, Katori M: Inhibition of kinin formation by a kallikrein inhibition during extracorporeal circulation in open-heart surgery. Circulation 52: 325-332, 1975.
4. Ratcliffe JM, Elliot MJ, Wyse RKH: The metabolic load stored blood. Implications for major transfusions in infants. Arch Dis Child 61: 1208-1214, 1986.
5. Margolius HS: Kallikreins and kinins. Molecular characteristics and cellular and tissue responses. Diabetes 45(suppl 1): S14-519, 1996.
6. Busse R, Fleming I: Molecular responses of endothelial tissue to kinins. Diabetes 45(suppl 1): S8-S13, 1996.
7. Mombouli J-V, Vanhoutte PM: Kinins and endothelial control of vascular smmoth muscle. Annu Rev Pharmacol Toxicol 35: 679-705, 1995.
8. Linz W, Wiemer G, Cohlke P, Unger T, Scholkens BA: Contribution of kinins to the cardiovascular actions of angiotensin: converting enzyme inhibitors. Pharmacol Rev 47: 25-49, 1995.